The stock price of GE HealthCare Technologies Inc (NASDAQ: GEHC) has surged by 6.24 when compared to previous closing price of 69.87, but the company has seen a 7.01% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-05-12 that HONOLULU–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical and research areas. The need for advanced diagnostics in cardiology and oncology continues to grow, with cardiovascular di.
Is It Worth Investing in GE HealthCare Technologies Inc (NASDAQ: GEHC) Right Now?
The price-to-earnings ratio for GE HealthCare Technologies Inc (NASDAQ: GEHC) is above average at 15.61x. The 36-month beta value for GEHC is also noteworthy at 1.38. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 4 rating it as “overweight,” 5 rating it as “hold,” and 1 rating it as “sell.”
The public float for GEHC is 456.67M, and at present, short sellers hold a 1.46% of that float. The average trading volume of GEHC on May 12, 2025 was 4.92M shares.
GEHC’s Market Performance
The stock of GE HealthCare Technologies Inc (GEHC) has seen a 7.01% increase in the past week, with a 19.19% rise in the past month, and a -15.17% fall in the past quarter. The volatility ratio for the week is 2.92%, and the volatility levels for the past 30 days are at 3.50% for GEHC. The simple moving average for the past 20 days is 10.92% for GEHC’s stock, with a -10.35% simple moving average for the past 200 days.
Analysts’ Opinion of GEHC
Many brokerage firms have already submitted their reports for GEHC stocks, with UBS repeating the rating for GEHC by listing it as a “Neutral.” The predicted price for GEHC in the upcoming period, according to UBS is $73 based on the research report published on May 05, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $100, previously predicting the price at $85. The rating they have provided for GEHC stocks is “Buy” according to the report published on March 11th, 2025.
Jefferies gave a rating of “Buy” to GEHC, setting the target price at $103 in the report published on January 08th of the current year.
GEHC Trading at 0.77% from the 50-Day Moving Average
After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.70% of loss for the given period.
Volatility was left at 3.50%, however, over the last 30 days, the volatility rate increased by 2.92%, as shares surge +18.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.44% lower at present.
During the last 5 trading sessions, GEHC rose by +7.74%, which changed the moving average for the period of 200-days by -6.21% in comparison to the 20-day moving average, which settled at $66.95. In addition, GE HealthCare Technologies Inc saw -5.05% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GEHC starting from Newcomb George A., who sale 2,000 shares at the price of $92.54 back on Feb 18 ’25. After this action, Newcomb George A. now owns 7,462 shares of GE HealthCare Technologies Inc, valued at $185,080 using the latest closing price.
Rott Roland, the CEO, Imaging of GE HealthCare Technologies Inc, sale 3,577 shares at $86.48 during a trade that took place back on Nov 06 ’24, which means that Rott Roland is holding 24,298 shares at $309,339 based on the most recent closing price.
Stock Fundamentals for GEHC
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.42 for the gross margin
The net margin for GE HealthCare Technologies Inc stands at 0.11. The total capital return value is set at 0.12. Equity return is now at value 26.32, with 6.64 for asset returns.
Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at 0.17. The debt to equity ratio resting at 1.0. The interest coverage ratio of the stock is 5.73.
Currently, EBITDA for the company is 3.68 billion with net debt to EBITDA at 1.92. When we switch over and look at the enterprise to sales, we see a ratio of 2.06. The receivables turnover for the company is 4.55for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
In summary, GE HealthCare Technologies Inc (GEHC) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
